NCT05676619

Brief Summary

The investigators will carry out a proof-of-concept study in 20 adult healthy male and female volunteers in order to: assess a 3D foot scanner's reliability. Specifically, the investigators will assess its variability during repeated foot scans of the same subject's foot. Three repeated foot scans will be carried out by two different examiners to measure intrarater and interrater reliability (Intraclass Correlation Coefficient

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 19, 2022

Completed
21 days until next milestone

First Posted

Study publicly available on registry

January 9, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

February 16, 2023

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 14, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 14, 2024

Completed
Last Updated

May 8, 2024

Status Verified

May 1, 2023

Enrollment Period

1.2 years

First QC Date

December 19, 2022

Last Update Submit

May 7, 2024

Conditions

Keywords

3D foot scan3D foot scannerfoot scanreliabilityrepeatability

Outcome Measures

Primary Outcomes (2)

  • Intrarater reliability (Intraclass Correlation Coefficient) of 3D foot scans repeated at baseline (change)

    (i) Intrarater reliability (Intraclass Correlation Coefficient) based on three scans of the same subject's foot whilst half-weightbearing carried out by the same 'rater' i.e. person using the 3D foot scanner;

    Repeated scans at baseline

  • Interrater reliability (Intraclass Correlation Coefficient) of 3D foot scans repeated at baseline (change)

    (ii) Interrater reliability (Intraclass Correlation Coefficient) based on three scans of the same subject's foot first by one rater (as above) and then by a second rater

    Repeated scans at baseline

Study Arms (1)

Single cohort of healthy volunteers

OTHER

Single cohort of healthy volunteers

Device: 3D foot scanner

Interventions

Reliability of 3D foot scanner during repeated scans

Single cohort of healthy volunteers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy men and women aged 18 years or over
  • Able to walk unaided
  • Able to walk up steps (the 3D scanner requires a small step on to the device to enter the correct position for measurement)
  • Willingness and capacity to participate in the study and to sign the informed consent form

You may not qualify if:

  • Diabetes mellitus diagnosis
  • Inability to ambulate independently without walking aids
  • No obvious foot deformities
  • No history of foot surgery
  • No pain, injuries or medical conditions affecting the legs or lower back
  • Any issues around balance (participants must remain standing in position for the approximately fifteen seconds required to obtain the 3D scan of their feet)
  • Health conditions that impact foot morphology

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Leicester General Hospital

Leicester, LE5 4PW, United Kingdom

Location

MeSH Terms

Conditions

Diabetes Complications

Condition Hierarchy (Ancestors)

Diabetes MellitusEndocrine System Diseases

Study Officials

  • Petra J Jones

    University Hospitals, Leicester

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 19, 2022

First Posted

January 9, 2023

Study Start

February 16, 2023

Primary Completion

April 14, 2024

Study Completion

April 14, 2024

Last Updated

May 8, 2024

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

There is no plan to make individual participant data (IPD) available to other researchers

Locations